1. Home
  2. PT vs PHIO Comparison

PT vs PHIO Comparison

Compare PT & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pintec Technology Holdings Limited

PT

Pintec Technology Holdings Limited

HOLD

Current Price

$1.01

Market Cap

14.7M

Sector

Technology

ML Signal

HOLD

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.21

Market Cap

12.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PT
PHIO
Founded
2012
2011
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
12.3M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
PT
PHIO
Price
$1.01
$1.21
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.67
AVG Volume (30 Days)
68.2K
429.4K
Earning Date
09-19-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,961,892.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.20
N/A
52 Week Low
$0.76
$0.97
52 Week High
$1.38
$9.79

Technical Indicators

Market Signals
Indicator
PT
PHIO
Relative Strength Index (RSI) 58.23 52.95
Support Level $0.92 $1.00
Resistance Level $0.99 $1.18
Average True Range (ATR) 0.05 0.07
MACD 0.01 0.03
Stochastic Oscillator 80.00 93.18

Price Performance

Historical Comparison
PT
PHIO

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Share on Social Networks: